NCT05429515 Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury Status NOT_YET_RECRUITING Phase PHASE4
NCT05428163 Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients Status COMPLETED Phase N/A
NCT05422027 Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05414162 Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy Status RECRUITING Phase N/A
NCT05412329 Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma Status UNKNOWN Phase PHASE1
NCT05405387 Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT05396885 Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05393804 A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05393024 Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy Status COMPLETED Phase N/A
NCT05381077 Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner Status UNKNOWN Phase NA
NCT05378971 Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma Status RECRUITING Phase NA
NCT05372354 A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease Status RECRUITING Phase N/A
NCT05364177 68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma Status UNKNOWN Phase EARLY_PHASE1
NCT05361694 Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions Status RECRUITING Phase N/A
NCT05355987 Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma Status COMPLETED Phase NA
NCT05354557 Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05347485 A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT05346835 Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma Status AVAILABLE Phase N/A
NCT05346809 Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma Status RECRUITING Phase PHASE2